Showing 7221-7230 of 23138 results for "".
Final Exam: A Surgeon's Reflections on Mortality
https://reachmd.com/programs/book-club/final-exam-a-surgeons-reflections-on-mortality-1/6827/When Dr. Pauline Chen began medical school, she dreamed of saving lives. What she could not predict was how much death would be a part of her work. Almost immediately, she found herself wrestling with medicine's most profound paradox-that a profession premised on caring for the ill also systematicalThe Remarkable Discovery of Helicobacter pylori
https://reachmd.com/programs/clinicians-roundtable/the-remarkable-discovery-of-helicobacter-pylori/4895/After failed attempts to infect piglets with H.pylori in 1984, Dr. Barry Marshall decided to use himself as an animal model and drank from a petri dish cultured with the bacteria. His resultant development of gastritis, and the subsequent discovery of H.pylori's role in gastric ulcer disease pathogeDiagnosing and Tracking the Progression of MacTel Type 2
https://reachmd.com/programs/cme/Diagnosing-and-Tracking-the-Progression-of-MacTel-Type-2/35964/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.FUE vs FUT: Key Considerations for Patient Selection
https://reachmd.com/programs/dermconsult/fue-fut-patient-selection-considerations/49026/Understanding the differences between follicular unit extraction (FUE) and follicular unit transplantation (FUT) is essential for selecting the most appropriate approach for each patient. Dr. Marc Avram shares how harvesting methods, scarring patterns, and other patient-specific consideratioIndividualizing gMG Treatment: Defining Success With Each Patient
https://reachmd.com/programs/neurofrontiers/individualizing-gmg-treatment-defining-success-with-each-patient/32862/As treatment options for generalized myasthenia gravis (gMG) expand, defining success means more than just controlling symptoms—it means aligning care with each patient’s goals and lifestyle. Hear Dr. Omar Sinno, who spoke with ReachMD at the AANEM 2025 Annual Meeting in San Francisco, share insightNavigating Fertility Preservation in Young Patients With Endometrial Cancer
https://reachmd.com/programs/project-oncology/navigating-fertility-preservation-in-young-patients-with-endometrial-cancer/36397/Endometrial cancer is increasingly affecting younger patients, many of whom wish to preserve fertility—a challenge compounded by limited access to assisted reproductive technologies. Dr. Kathleen Moore explores established fertility-sparing regimens, including hormonal therapies and IUD-basedOptimizing DMD Care Through Multidisciplinary Collaboration
https://reachmd.com/programs/neurofrontiers/optimizing-dmd-care-through-multidisciplinary-collaboration/35683/Due to its multisystemic nature, Duchenne muscular dystrophy (DMD) demands a collaborative, multidisciplinary approach. That’s why Dr. Kaitlin Batley joins us to share her insights on the essential role of integrated care teams—spanning cardiology, pulmonology, endocrinology, rehabilitation, palliatSlow Medicine: The Way to Healing
https://reachmd.com/programs/book-club/slow-medicine-way-healing/10613/Issues like physician burnout, bad outcomes, and unhappy patients are plaguing medicine, but could something as simple as slowing down be the answer?More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
https://reachmd.com/programs/global-womens-health-academy/more-than-womens-issues-womens-reproductive-and-gynaecological-health-and-work/9819/This article will review areas of women’s reproductive and gynaecological health, and shine light on what those mean in terms of the workplace.From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer
https://reachmd.com/programs/clinicians-roundtable/from-silent-killer-treatable-disease-improved-detection-methods-ovarian-cancer/7929/From the American Cancer Society, ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. A woman's risk of getting ovarian cancer during her lifetime is about 1 in 75. Her lifetime chance of dying from ovarian canc